Coronavirus questions: 10 things we still urgently want to know about COVID-19 in the next 100 days – USA TODAY

America hit a somber benchmark in the coronavirus pandemic, with the U.S. death toll reaching 100,000. USA TODAY

Doctors, scientistsand epidemiologistshave made strides in their research to learn what they can about SARS-CoV-2and the illness it causes, COVID-19.

Multiple vaccines are in different stages of development asinstitutions scrutinize the effectiveness of existing drugs to treat coronavirus patients in clinical trials. Social distancing restrictions and lockdown measures have flattened the curve in parts of the country, and states have begun reopening in phases.

But experts say that there's more to learn about the virus, and as theUnited States surpasses 100,000 deaths, many wonder if that learning curve is just too steep.

The loss is staggering:Honoring the 100,000 lives lost to the coronavirus

Lets take a moment to honor the lives of those we have lost, and begin to comprehend the wound they leave behind.

These are the top 10 questionswe hope to have answers to in the next 100 days.

This is the number one No. 1 question on everybody's mind. Unfortunately, the answer is complicated.

President Donald Trump announced this month the launch of Operation Warp Speed,a government coordinating effort aimed at securing acoronavirus vaccine by the end of the year.

But vaccine experts have consistently urged caution in presuming a vaccine will be available soon. The White HouseCoronavirus Task Force's Dr. Anthony Fauci has said that a vaccine islikely within the next year or two, and the process takes time.

"You can rush vaccine development,but only when you understand theres no way around it you are trading safety for speed," saidDr. Greg Poland, director of the Mayo Clinic's Vaccine Research Group.

Oxford University in England andMaryland-based vaccine company Novavax seem ahead of the global race as their vaccine candidates have shown success in animal trials.

But many experts say the process will be even longer as mass production to make the vaccine widely available to everyone at once is nearly impossible. The government will be forced to decide who will receive the vaccine first and allocate doses accordingly.

Sad milestone: Coronavirus death toll reaches 100,000 in U.S.

Mitch Albom: 100,000 Americans are dead. Were all potential victims and killers

While testing has accelerated since the Centers for Disease Control and Prevention stumbled in its initialrollout, it's still not perfect.

Many parts of the country still reserve tests only for patients who present symptoms.

"If you are symptomatic with a respiratory illness, that is an indication for a test and you can get a test. If you need to be contact traced, you can get a test," said Adm. Brett Giroir, the assistant secretary for health at the Department of Health and Human Services.

But studies have shown that many infected people never present symptoms, and public health experts have called for enough testing to reveal the asymptomatic carriers of the disease.

Trump said 300,000 tests are now being donenationwide every day. But last week, areport from theHarvard Global Health Institutefound that the U.S. should be doing 900,000 tests a day by May 15 to safely reopen.

According to their model, more than 40 states have not reached the level of testing needed, including four Colorado, Florida, Georgia and Texas that have already reopened.

Autoplay

Show Thumbnails

Show Captions

Experts say people should be careful about how they interpretresults of COVID-19 antibody teststhat haven't been validated by government regulators asmanufacturers flooded the U.S. market withtests that vary widely in accuracy.

The U.S. Food and Drug Administration made therush to market possible by allowingCOVID-19 antibody test manufacturers to self-validate their products without first submitting the data to regulators.

Amid criticism of that policy, theFDA changed coursein early May. Citing unnamed unscrupulous actors marketing fraudulent tests, the agencysaid manufacturers must meet new accuracy standards and submit proof of testing quality.

At that point, the FDA had given emergency use approval to 12 out of more than 200 antibody test manufacturers.The FDA is working with other government officesto assess the performance of antibody tests. Results have not been made public.But even if antibody testing gets more accurate with the FDA's new guidelines, experts still can't confirm the presence of antibodies mean immunity to the virus.

Next 100 days: How the coronavirus will continue to change your life

10 important lessons: As it hits 100K deaths, has the US learned anything?

As experts race to find a treatment for COVID-19,the experimental drug remdesiviris showing some promise. Data from a global study released at the end of Aprilfound patients given the drug recovered faster and may be less likely to die.

The study, conducted by the U.S. National Institute of Allergy and Infectious Diseases, found patients who received remdesivir had a 31% faster recovery time than those who received a placebo.

Remdesivir is an experimental antiviral drug from the American biotech firm GileadSciences. It was originally tested as a treatment for Ebola and other coronaviruses including SARS and is now being tested as a possible COVID-19 treatment.

Many scientists caution, however, against drawing any conclusions about remdesivir and say other recent studies found no clinical benefits to the drug.

As coronavirus spreads, people are getting more cautious and creative with their social interactions. USA TODAY

Convalescent plasmaandimmunomodulators liketocilizumabhave been given to patients with COVID-19 in clinical trials, but remdesivir is the only treatment that has been shown tohave even a potential effect on the disease.

Trump confirmed to reporters May 18that he hadbeen taking the anti-malaria drug hydroxychloroquinedaily for the past week and a half;however, there has been no solid evidence ofthe drug's effectiveness. In fact, doctors caution against using hydroxychloroquine outside of its intended purpose or in clinical trials as the long list of side effects can be harmful.

Concern for reinfection was initially raised after reports out ofSouth Korea that some people were becoming reinfected with SARS-CoV-2, the virus that causes COVID-19.

The countrys Centers for Disease Control and Preventionreported more than300 such cases.South Korea has one of the worlds most extensive COVID-19 testing programs, so its data is considered strong.

South Korean researchers now believe theywere seeing false positives, in which the tests detected old particles of virus in patients no longer causing disease,Reuters reported.

Its still not known whether having had COVID-19 gives long-term immunity to the virus, but immediate reinfection is now less of a worry.

Timeline: Four months in: A look at how COVID-19 has unfolded in the US

Losing Rhoda: Chicago family struggles to grieve matriarch,friends taken by virus

As states gradually reopen, the questionthat loomsin the coming weeks is whether increased resident mobility leads to a surgein new coronavirus cases.

Texas could be a telling case. The state became one of the first to take aggressive measures, allowing restaurants and retailers to reopen to limited customer capacity May 1. On May 14, Texas reported its highest single-day increase of new cases, with 1,448,according to the Johns Hopkins University data dashboard.

Fauci, director of the National Institute of Allergy and Infectious Diseases, warned May 12 in a Senate committee hearing that reopening the country amid thecoronavirus pandemic may lead to "some suffering and death."

But experts say it'sunlikely we'llsee a rise in cases in the next few weeks as states reopen for the summer. Officials say we'remorelikely to see that surge in late summer or fall because the coronavirus incubation spans from about five days to 11 days.

Autoplay

Show Thumbnails

Show Captions

Even as states reopen, officials warn residents that life won't be as they knew it.

Instead, they should expect a "new normal" where sports stadiums remain emptyand national parks offer limited services for their visitors.

TheTransportation Security Administration announced changes to its screeningprocess to include social distancing measures, relaxed carry-on liquid requirements and boarding pass etiquette.

Restaurants were forced to think creatively as they reopened. Some are allowing customers to sit outside on their deck or patio at 50% occupancy. Cities in Florida, Nevada and Maine temporarily closed their streets to allow diners to eat comfortably and safely on the street.

A restaurant in Ocean City, Maryland,created special tables with oversized inner tubes to keep all clients at least 6 feet apart.

"It's like a bumper boat, but it's actually a table," owner Shawn Harmon said. .

The health care landscape has drastically changed since the pandemic arrived in the United States.

Doctors restructured office waiting rooms and now greetpatients who are daring enough to keep regular visits wearing masks. Hospitals cut elective surgeries, limited visitors and scrambled to provide protection for workers.Tests and annual checkups have been postponedor converted to virtual visits.

Precautions affectingthe way most Americans access basic health care are expected to last. Without a vaccine not expected even optimistically until sometime next year the risk of transmitting thevirus that causes COVID-19 remains high.

Tips to minimize risk: Leaving your coronavirus isolation? Think about these 3 things first

So what will the future of medicine look like as the U.S. adapts to the new pandemic landscape? Expect more remote doctor visits, tenuous hospital care in rural areas and increased preparedness.

For years, weve talked about the promise of telemedicine and its opportunities, said Mark Holmes, professor at University of North Carolina Gillings School of Global Public Health. But what the last two months has shown us is that it could really be a game-changer.

Elections are still being heldthroughout the country even as the threat of infection looms over the heads of voters.

Wisconsin's Supreme Court overturned the state's stay-at-home orders, and April's primary resumed;some voters stood in line for hours in the midst of a pandemic.Thousands of absentee ballots either werent sent outor ended uplost in the mail, and others were returned too late to be counted.

Five states allow voters to cast their ballots from home in all of their elections: Colorado, Hawaii, Oregon,Washington and Utah.Those states send registered voters a ballot at least seven days before an election tofill it out at their convenience, and voterseither mail it back or drop it off at any center that's closest to them.

While a vote-at-home system may be more efficient overall, the startup costs of implementing itcould be substantial. But experts say theymay becheaper over time as the cost of poll workers are much lower.

Autoplay

Show Thumbnails

Show Captions

And so far, states that use vote-at-home have seen increases in turnout.In a 2019 studyof Utah, 21 out of 29 counties conducted general elections by mail. Voter turnout in that 2016 election was 8.7 points higher in the counties that implemented vote-at-home than in those that had not.

Trump has repeatedlytweeted his oppositionto such plans and just this week threatenedto cut off federal fundingto two states, Michigan and Nevada over mail voting. Trump and other Republicans have argued that a vote-at-home system has tremendous potential for voter fraud.

But advocacy groups such as the National Vote at Home Institute and the Brennan Center for Justice strongly dispute suchclaims.

Before the outbreak, the U.S. Census Bureau had planned to hire as many as 500,000 workers to knock on doors and get households that didn't respond to answer the survey.

While those hiring efforts are underway online, the agency was forced to suspend field operations in March and only recently restartedthose operations in phases. As of May 18, a handful of Area Census Offices made the list.

Agency officials continued to urge people to respond to the Census online, by mail or by phone. Invitations to respond started arriving in households last week.

"We recognize that many people plan to access the 2020 Census through other response modes, such as phone or paper, which is why the 2020 Census has such a nimble design,'' the agency said in a statement.

Plans forthe nationwide count have been underway for years. The population survey is key to apportioning Congressional districts and determining the distribution of billions in federal fundsforschools, infrastructureand health systems.

Contributing: Deborah Barfield Berry,Elizabeth Weise, William Cummings,Kevin McCoy, David Heath, Joel Shannon, Lorenzo Reyes and Doyle Rice, USA TODAY; and Patricia McKnight, Milwaukee Journal Sentinel. Follow Adrianna Rodriguez on Twitter: @AdriannaUSAT.

Autoplay

Show Thumbnails

Show Captions

Read or Share this story: https://www.usatoday.com/story/news/health/2020/05/27/coronavirus-covid-19-pandemic-10-questions-answers-us-death-toll-100-k/5229575002/

See more here:

Coronavirus questions: 10 things we still urgently want to know about COVID-19 in the next 100 days - USA TODAY